Global Risperidone Market Report, History and Forecast 2017-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application

Publisher Name :
Date: 07-Nov-2022
No. of pages: 106
Inquire Before Buying

Market Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Risperidone estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

North American market for Risperidone is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

Asia-Pacific market for Risperidone is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

Europe market for Risperidone is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Risperidone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Risperidone.

The Risperidone market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Risperidone market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Risperidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

Market Segmentation

This report covers the Risperidone segments by manufacturers, by type, by application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

By Company

- Janssen (Johnson & Johnson)

- Ajanta Pharma

- Amneal Pharmaceuticals

- Aurobindo Pharma

- Hikma

- Sandoz

- Lannett

- Tris Pharma

- Apotex

- Celltrion

- Dr. Reddy's Laboratories

- Torrent Pharmaceuticals

- Luye Pharma Group

Risperidone Segment by Type

- Tablet

- Oral Solution

Risperidone Segment by Application

- Schizophrenia

- Bipolar Disorder

Risperidone segment by Region

- North America (USA and Canada)

- Europe (Germany, the U.K., France, Russia, Italy, Rest of Europe)

- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

- South America (Mexico, Brazil, Rest of South America)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA)

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Risperidone market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

Informative and detailed data, sales, revenue, average price, historical and forecast data, which is analyzed to tell you why your market is set to change. Provision of market value (USD million) data for each segment and sub-segment.

This report will help stakeholders to understand the global industry status and trends of Risperidone and provides them with information on key market drivers, restraints, challenges, and opportunities. This enables you to anticipate market changes to remain ahead of your competitors.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition. This concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly.

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Risperidone industry. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by type, market size by type for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter Two: Detailed analysis of Risperidone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Three: Sales, revenue of Risperidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter Four: Introduces market segments by application, market size by application for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter Eleven and Twelve: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter Thirteen: Research Findings and Conclusion

Global Risperidone Market Report, History and Forecast 2017-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application

Table of Contents
1 Risperidone Market Overview
1.1 Risperidone Product Overview
1.2 Risperidone Market Segment by Type
1.2.1 Tablet
1.2.2 Oral Solution
1.3 Global Risperidone Market Size by Type
1.3.1 Global Risperidone Market Size Overview by Type (2017-2028)
1.3.2 Global Risperidone Historic Market Size Review by Type (2017-2022)
1.3.2.1 Global Risperidone Sales Breakdown in Volume by Type (2017-2022)
1.3.2.2 Global Risperidone Sales Breakdown in Value by Type (2017-2022)
1.3.2.3 Global Risperidone Average Selling Price (ASP) by Type (2017-2022)
1.3.3 Global Risperidone Forecasted Market Size by Type (2023-2028)
1.3.3.1 Global Risperidone Sales Breakdown in Volume by Type (2023-2028)
1.3.3.2 Global Risperidone Sales Breakdown in Value by Type (2023-2028)
1.3.3.3 Global Risperidone Average Selling Price (ASP) by Type (2023-2028)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Risperidone Sales Breakdown by Type (2017-2022)
1.4.2 Europe Risperidone Sales Breakdown by Type (2017-2022)
1.4.3 Asia-Pacific Risperidone Sales Breakdown by Type (2017-2022)
1.4.4 South America Risperidone Sales Breakdown by Type (2017-2022)
1.4.5 Middle East and Africa Risperidone Sales Breakdown by Type (2017-2022)
2 Global Risperidone Market Competition by Company
2.1 Global Top Players by Risperidone Sales (2017-2022)
2.2 Global Top Players by Risperidone Revenue (2017-2022)
2.3 Global Top Players Risperidone Price (2017-2022)
2.4 Global Top Manufacturers Risperidone Manufacturing Base Distribution, Sales Area, Product Type
2.5 Risperidone Market Competitive Situation and Trends
2.5.1 Risperidone Market Concentration Rate (2017-2022)
2.5.2 Global 5 and 10 Largest Manufacturers by Risperidone Sales and Revenue in 2021
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Risperidone as of 2021)
2.7 Date of Key Manufacturers Enter into Risperidone Market
2.8 Key Manufacturers Risperidone Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Risperidone Status and Outlook by Region
3.1 Global Risperidone Market Size and CAGR by Region: 2017 VS 2021 VS 2028
3.2 Global Risperidone Historic Market Size by Region
3.2.1 Global Risperidone Sales in Volume by Region (2017-2022)
3.2.2 Global Risperidone Sales in Value by Region (2017-2022)
3.2.3 Global Risperidone Sales (Volume & Value) Price and Gross Margin (2017-2022)
3.3 Global Risperidone Forecasted Market Size by Region
3.3.1 Global Risperidone Sales in Volume by Region (2023-2028)
3.3.2 Global Risperidone Sales in Value by Region (2023-2028)
3.3.3 Global Risperidone Sales (Volume & Value), Price and Gross Margin (2023-2028)
4 Global Risperidone by Application
4.1 Risperidone Market Segment by Application
4.1.1 Schizophrenia
4.1.2 Bipolar Disorder
4.2 Global Risperidone Market Size by Application
4.2.1 Global Risperidone Market Size Overview by Application (2017-2028)
4.2.2 Global Risperidone Historic Market Size Review by Application (2017-2022)
4.2.2.1 Global Risperidone Sales Breakdown in Volume, by Application (2017-2022)
4.2.2.2 Global Risperidone Sales Breakdown in Value, by Application (2017-2022)
4.2.2.3 Global Risperidone Average Selling Price (ASP) by Application (2017-2022)
4.2.3 Global Risperidone Forecasted Market Size by Application (2023-2028)
4.2.3.1 Global Risperidone Sales Breakdown in Volume, by Application (2023-2028)
4.2.3.2 Global Risperidone Sales Breakdown in Value, by Application (2023-2028)
4.2.3.3 Global Risperidone Average Selling Price (ASP) by Application (2023-2028)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Risperidone Sales Breakdown by Application (2017-2022)
4.3.2 Europe Risperidone Sales Breakdown by Application (2017-2022)
4.3.3 Asia-Pacific Risperidone Sales Breakdown by Application (2017-2022)
4.3.4 South America Risperidone Sales Breakdown by Application (2017-2022)
4.3.5 Middle East and Africa Risperidone Sales Breakdown by Application (2017-2022)
5 North America Risperidone by Country
5.1 North America Risperidone Historic Market Size by Country
5.1.1 North America Risperidone Sales in Volume by Country (2017-2022)
5.1.2 North America Risperidone Sales in Value by Country (2017-2022)
5.2 North America Risperidone Forecasted Market Size by Country
5.2.1 North America Risperidone Sales in Volume by Country (2023-2028)
5.2.2 North America Risperidone Sales in Value by Country (2023-2028)
6 Europe Risperidone by Country
6.1 Europe Risperidone Historic Market Size by Country
6.1.1 Europe Risperidone Sales in Volume by Country (2017-2022)
6.1.2 Europe Risperidone Sales in Value by Country (2017-2022)
6.2 Europe Risperidone Forecasted Market Size by Country
6.2.1 Europe Risperidone Sales in Volume by Country (2023-2028)
6.2.2 Europe Risperidone Sales in Value by Country (2023-2028)
7 Asia-Pacific Risperidone by Region
7.1 Asia-Pacific Risperidone Historic Market Size by Region
7.1.1 Asia-Pacific Risperidone Sales in Volume by Region (2017-2022)
7.1.2 Asia-Pacific Risperidone Sales in Value by Region (2017-2022)
7.2 Asia-Pacific Risperidone Forecasted Market Size by Region
7.2.1 Asia-Pacific Risperidone Sales in Volume by Region (2023-2028)
7.2.2 Asia-Pacific Risperidone Sales in Value by Region (2023-2028)
8 South America Risperidone by Country
8.1 South America Risperidone Historic Market Size by Country
8.1.1 South America Risperidone Sales in Volume by Country (2017-2022)
8.1.2 South America Risperidone Sales in Value by Country (2017-2022)
8.2 South America Risperidone Forecasted Market Size by Country
8.2.1 South America Risperidone Sales in Volume by Country (2023-2028)
8.2.2 South America Risperidone Sales in Value by Country (2023-2028)
9 Middle East and Africa Risperidone by Country
9.1 Middle East and Africa Risperidone Historic Market Size by Country
9.1.1 Middle East and Africa Risperidone Sales in Volume by Country (2017-2022)
9.1.2 Middle East and Africa Risperidone Sales in Value by Country (2017-2022)
9.2 Middle East and Africa Risperidone Forecasted Market Size by Country
9.2.1 Middle East and Africa Risperidone Sales in Volume by Country (2023-2028)
9.2.2 Middle East and Africa Risperidone Sales in Value by Country (2023-2028)
10 Company Profiles and Key Figures in Risperidone Business
10.1 Janssen (Johnson & Johnson)
10.1.1 Janssen (Johnson & Johnson) Corporation Information
10.1.2 Janssen (Johnson & Johnson) Introduction and Business Overview
10.1.3 Janssen (Johnson & Johnson) Risperidone Sales, Revenue and Gross Margin (2017-2022)
10.1.4 Janssen (Johnson & Johnson) Risperidone Products Offered
10.1.5 Janssen (Johnson & Johnson) Recent Development
10.2 Ajanta Pharma
10.2.1 Ajanta Pharma Corporation Information
10.2.2 Ajanta Pharma Introduction and Business Overview
10.2.3 Ajanta Pharma Risperidone Sales, Revenue and Gross Margin (2017-2022)
10.2.4 Ajanta Pharma Risperidone Products Offered
10.2.5 Ajanta Pharma Recent Development
10.3 Amneal Pharmaceuticals
10.3.1 Amneal Pharmaceuticals Corporation Information
10.3.2 Amneal Pharmaceuticals Introduction and Business Overview
10.3.3 Amneal Pharmaceuticals Risperidone Sales, Revenue and Gross Margin (2017-2022)
10.3.4 Amneal Pharmaceuticals Risperidone Products Offered
10.3.5 Amneal Pharmaceuticals Recent Development
10.4 Aurobindo Pharma
10.4.1 Aurobindo Pharma Corporation Information
10.4.2 Aurobindo Pharma Introduction and Business Overview
10.4.3 Aurobindo Pharma Risperidone Sales, Revenue and Gross Margin (2017-2022)
10.4.4 Aurobindo Pharma Risperidone Products Offered
10.4.5 Aurobindo Pharma Recent Development
10.5 Hikma
10.5.1 Hikma Corporation Information
10.5.2 Hikma Introduction and Business Overview
10.5.3 Hikma Risperidone Sales, Revenue and Gross Margin (2017-2022)
10.5.4 Hikma Risperidone Products Offered
10.5.5 Hikma Recent Development
10.6 Sandoz
10.6.1 Sandoz Corporation Information
10.6.2 Sandoz Introduction and Business Overview
10.6.3 Sandoz Risperidone Sales, Revenue and Gross Margin (2017-2022)
10.6.4 Sandoz Risperidone Products Offered
10.6.5 Sandoz Recent Development
10.7 Lannett
10.7.1 Lannett Corporation Information
10.7.2 Lannett Introduction and Business Overview
10.7.3 Lannett Risperidone Sales, Revenue and Gross Margin (2017-2022)
10.7.4 Lannett Risperidone Products Offered
10.7.5 Lannett Recent Development
10.8 Tris Pharma
10.8.1 Tris Pharma Corporation Information
10.8.2 Tris Pharma Introduction and Business Overview
10.8.3 Tris Pharma Risperidone Sales, Revenue and Gross Margin (2017-2022)
10.8.4 Tris Pharma Risperidone Products Offered
10.8.5 Tris Pharma Recent Development
10.9 Apotex
10.9.1 Apotex Corporation Information
10.9.2 Apotex Introduction and Business Overview
10.9.3 Apotex Risperidone Sales, Revenue and Gross Margin (2017-2022)
10.9.4 Apotex Risperidone Products Offered
10.9.5 Apotex Recent Development
10.10 Celltrion
10.10.1 Celltrion Corporation Information
10.10.2 Celltrion Introduction and Business Overview
10.10.3 Celltrion Risperidone Sales, Revenue and Gross Margin (2017-2022)
10.10.4 Celltrion Risperidone Products Offered
10.10.5 Celltrion Recent Development
10.11 Dr. Reddy's Laboratories
10.11.1 Dr. Reddy's Laboratories Corporation Information
10.11.2 Dr. Reddy's Laboratories Introduction and Business Overview
10.11.3 Dr. Reddy's Laboratories Risperidone Sales, Revenue and Gross Margin (2017-2022)
10.11.4 Dr. Reddy's Laboratories Risperidone Products Offered
10.11.5 Dr. Reddy's Laboratories Recent Development
10.12 Torrent Pharmaceuticals
10.12.1 Torrent Pharmaceuticals Corporation Information
10.12.2 Torrent Pharmaceuticals Introduction and Business Overview
10.12.3 Torrent Pharmaceuticals Risperidone Sales, Revenue and Gross Margin (2017-2022)
10.12.4 Torrent Pharmaceuticals Risperidone Products Offered
10.12.5 Torrent Pharmaceuticals Recent Development
10.13 Luye Pharma Group
10.13.1 Luye Pharma Group Corporation Information
10.13.2 Luye Pharma Group Introduction and Business Overview
10.13.3 Luye Pharma Group Risperidone Sales, Revenue and Gross Margin (2017-2022)
10.13.4 Luye Pharma Group Risperidone Products Offered
10.13.5 Luye Pharma Group Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Risperidone Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Risperidone Industrial Chain Analysis
11.4 Risperidone Market Dynamics
11.4.1 Risperidone Industry Trends
11.4.2 Risperidone Market Drivers
11.4.3 Risperidone Market Challenges
11.4.4 Risperidone Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Risperidone Distributors
12.3 Risperidone Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Major Company of Tablet
Table 2. Major Company of Oral Solution
Table 3. Global Risperidone Sales by Type 2017 VS 2021 VS 2028 (US$ Million)
Table 4. Global Risperidone Sales by Type (2017-2022) & (K Pcs)
Table 5. Global Risperidone Sales Market Share in Volume by Type (2017-2022)
Table 6. Global Risperidone Sales by Type (2017-2022) & (US& Million)
Table 7. Global Risperidone Market Share in Value by Type (2017-2022)
Table 8. Global Risperidone Price by Type (2017-2022) & (US$/Pcs)
Table 9. Global Risperidone Sales by Type (2023-2028) & (K Pcs)
Table 10. Global Risperidone Sales Market Share in Volume by Type (2023-2028)
Table 11. Global Risperidone Sales by Type (2023-2028) & (US$ Million)
Table 12. Global Risperidone Sales Market Share in Value by Type (2023-2028)
Table 13. Global Risperidone Price by Type (2023-2028) & (US$/Pcs)
Table 14. North America Risperidone Sales by Type (2017-2022) & (K Pcs)
Table 15. North America Risperidone Sales by Type (2017-2022) & (US$ Million)
Table 16. Europe Risperidone Sales (K Pcs) by Type (2017-2022)
Table 17. Europe Risperidone Sales by Type (2017-2022) & (US$ Million)
Table 18. Asia-Pacific Risperidone Sales (K Pcs) by Type (2017-2022)
Table 19. Asia-Pacific Risperidone Sales by Type (2017-2022) & (US$ Million)
Table 20. South America Risperidone Sales (K Pcs) by Type (2017-2022)
Table 21. South America Risperidone Sales by Type (2017-2022) & (US$ Million)
Table 22. Middle East and Africa Risperidone Sales (K Pcs) by Type (2017-2022)
Table 23. Middle East and Africa Risperidone Sales by Type (2017-2022) & (US$ Million)
Table 24. Global Risperidone Sales by Company (2017-2022) & (K Pcs)
Table 25. Global Risperidone Sales Share by Company (2017-2022)
Table 26. Global Risperidone Revenue by Company (2017-2022) & (US$ Million)
Table 27. Global Risperidone Revenue Share by Company (2017-2022)
Table 28. Global Market Risperidone Price by Company (2017-2022) & (US$/Pcs)
Table 29. Global Risperidone Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Risperidone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Risperidone as of 2021)
Table 32. Date of Key Manufacturers Enter into Risperidone Market
Table 33. Key Manufacturers Risperidone Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Risperidone Market Size Comparison by Region (US$ Million): 2017 VS 2021 VS 2028
Table 36. Global Risperidone Sales by Region (2017-2022) & (K Pcs)
Table 37. Global Risperidone Sales Market Share in Volume by Region (2017-2022)
Table 38. Global Risperidone Sales by Region (2017-2022) & (US$ Million)
Table 39. Global Risperidone Sales Market Share in Value by Region (2017-2022)
Table 40. Global Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 41. Global Risperidone Sales by Region (2023-2028) & (K Pcs)
Table 42. Global Risperidone Sales Market Share in Volume by Region (2023-2028)
Table 43. Global Risperidone Sales by Region (2023-2028) & (US$ Million)
Table 44. Global Risperidone Sales Market Share in Value by Region (2023-2028)
Table 45. Global Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2023-2028)
Table 46. Global Risperidone Sales by Application: 2017 VS 2021 VS 2028 (US$ Million)
Table 47. Global Risperidone Sales by Application (2017-2022) & (K Pcs)
Table 48. Global Risperidone Sales Market Share in Volume by Application (2017-2022)
Table 49. Global Risperidone Sales by Application (2017-2022) & (US$ Million)
Table 50. Global Risperidone Sales Market Share in Value by Application (2017-2022)
Table 51. Global Risperidone Price by Application (2017-2022) & (US$/Pcs)
Table 52. Global Risperidone Sales by Application (2023-2028) & (K Pcs)
Table 53. Global Risperidone Sales Market Share in Volume by Application (2023-2028)
Table 54. Global Risperidone Sales by Application (2023-2028) & (US$ Million)
Table 55. Global Risperidone Sales Market Share in Value by Application (2023-2028)
Table 56. Global Risperidone Price by Application (2023-2028) & (US$/Pcs)
Table 57. North America Risperidone Sales by Application (2017-2022) (K Pcs)
Table 58. North America Risperidone Sales by Application (2017-2022) & (US$ Million)
Table 59. North America Risperidone Sales Market Share in Value by Application in 2021
Table 60. Europe Risperidone Sales by Application (2017-2022) (K Pcs)
Table 61. Europe Risperidone Sales by Application (2017-2022) & (US$ Million)
Table 62. Europe Risperidone Sales Market Share in Value by Application in 2021
Table 63. Asia-Pacific Risperidone Sales by Application (2017-2022) (K Pcs)
Table 64. Asia-Pacific Risperidone Sales by Application (2017-2022) & (US$ Million)
Table 65. Asia-Pacific Risperidone Sales Market Share in Value by Application in 2021
Table 66. South America Risperidone Sales by Application (2017-2022) (K Pcs)
Table 67. South America Risperidone Sales by Application (2017-2022) & (US$ Million)
Table 68. South America Risperidone Sales Market Share in Value by Application in 2021
Table 69. Middle East and Africa Risperidone Sales by Application (2017-2022) (K Pcs)
Table 70. Middle East and Africa Risperidone Sales by Application (2017-2022) & (US$ Million)
Table 71. Middle East and Africa Risperidone Sales Market Share in Value by Application in 2021
Table 72. North America Risperidone Sales by Country (2017-2022) & (K Pcs)
Table 73. North America Risperidone Sales Market Share in Volume by Country (2017-2022)
Table 74. North America Risperidone Sales by Country (2017-2022) & (US$ Million)
Table 75. North America Risperidone Sales Market Share in Value by Country (2017-2022)
Table 76. North America Risperidone Sales by Country (2023-2028) & (K Pcs)
Table 77. North America Risperidone Sales Market Share in Volume by Country (2023-2028)
Table 78. North America Risperidone Sales by Country (2023-2028) & (US$ Million)
Table 79. North America Risperidone Sales Market Share in Value by Country (2023-2028)
Table 80. Europe Risperidone Sales by Country (2017-2022) & (K Pcs)
Table 81. Europe Risperidone Sales Market Share in Volume by Country (2017-2022)
Table 82. Europe Risperidone Sales by Country (2017-2022) & (US$ Million)
Table 83. Europe Risperidone Sales Market Share in Value by Country (2017-2022)
Table 84. Europe Risperidone Sales by Country (2023-2028) & (K Pcs)
Table 85. Europe Risperidone Sales Market Share in Volume by Country (2023-2028)
Table 86. Europe Risperidone Sales by Country (2023-2028) & (US$ Million)
Table 87. Europe Risperidone Sales Market Share in Value by Country (2023-2028)
Table 88. Asia-Pacific Risperidone Sales by Region (2017-2022) & (K Pcs)
Table 89. Asia-Pacific Risperidone Sales Market Share in Volume by Region (2017-2022)
Table 90. Asia-Pacific Risperidone Sales by Region (2017-2022) & (US$ Million)
Table 91. Asia-Pacific Risperidone Sales Market Share in Value by Region (2017-2022)
Table 92. Asia-Pacific Risperidone Sales by Region (2023-2028) & (K Pcs)
Table 93. Asia-Pacific Risperidone Sales Market Share in Volume by Region (2023-2028)
Table 94. Asia-Pacific Risperidone Sales by Region (2023-2028) & (US$ Million)
Table 95. Asia-Pacific Risperidone Sales Market Share in Value by Region (2023-2028)
Table 96. South America Risperidone Sales by Country (2017-2022) & (K Pcs)
Table 97. South America Risperidone Sales Market Share in Volume by Country (2017-2022)
Table 98. South America Risperidone Sales by Country (2017-2022) & (US$ Million)
Table 99. South America Risperidone Sales Market Share in Value by Country (2017-2022)
Table 100. South America Risperidone Sales by Country (2023-2028) & (K Pcs)
Table 101. South America Risperidone Sales Market Share in Volume by Country (2023-2028)
Table 102. South America Risperidone Sales by Country (2023-2028) & (US$ Million)
Table 103. South America Risperidone Sales Market Share in Value by Country (2023-2028)
Table 104. Middle East and Africa Risperidone Sales by Country (2017-2022) & (K Pcs)
Table 105. Middle East and Africa Risperidone Sales Market Share in Volume by Country (2017-2022)
Table 106. Middle East and Africa Risperidone Sales by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Risperidone Sales Market Share in Value by Country (2017-2022)
Table 108. Middle East and Africa Risperidone Sales by Country (2023-2028) & (K Pcs)
Table 109. Middle East and Africa Risperidone Sales Market Share in Volume by Country (2023-2028)
Table 110. Middle East and Africa Risperidone Sales by Country (2023-2028) & (US$ Million)
Table 111. Middle East and Africa Risperidone Sales Market Share in Value by Country (2023-2028)
Table 112. Janssen (Johnson & Johnson) Corporation Information
Table 113. Janssen (Johnson & Johnson) Introduction and Business Overview
Table 114. Janssen (Johnson & Johnson) Risperidone Sales (K Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 115. Janssen (Johnson & Johnson) Risperidone Product
Table 116. Janssen (Johnson & Johnson) Recent Development
Table 117. Ajanta Pharma Corporation Information
Table 118. Ajanta Pharma Introduction and Business Overview
Table 119. Ajanta Pharma Risperidone Sales (K Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 120. Ajanta Pharma Risperidone Product
Table 121. Ajanta Pharma Recent Development
Table 122. Amneal Pharmaceuticals Corporation Information
Table 123. Amneal Pharmaceuticals Introduction and Business Overview
Table 124. Amneal Pharmaceuticals Risperidone Sales (K Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 125. Amneal Pharmaceuticals Risperidone Product
Table 126. Amneal Pharmaceuticals Recent Development
Table 127. Aurobindo Pharma Corporation Information
Table 128. Aurobindo Pharma Introduction and Business Overview
Table 129. Aurobindo Pharma Risperidone Sales (K Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 130. Aurobindo Pharma Risperidone Product
Table 131. Aurobindo Pharma Recent Development
Table 132. Hikma Corporation Information
Table 133. Hikma Introduction and Business Overview
Table 134. Hikma Risperidone Sales (K Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 135. Hikma Risperidone Product
Table 136. Hikma Recent Development
Table 137. Sandoz Corporation Information
Table 138. Sandoz Introduction and Business Overview
Table 139. Sandoz Risperidone Sales (K Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 140. Sandoz Risperidone Product
Table 141. Sandoz Recent Development
Table 142. Lannett Corporation Information
Table 143. Lannett Introduction and Business Overview
Table 144. Lannett Risperidone Sales (K Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 145. Lannett Risperidone Product
Table 146. Lannett Recent Development
Table 147. Tris Pharma Corporation Information
Table 148. Tris Pharma Introduction and Business Overview
Table 149. Tris Pharma Risperidone Sales (K Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 150. Tris Pharma Risperidone Product
Table 151. Tris Pharma Recent Development
Table 152. Apotex Corporation Information
Table 153. Apotex Introduction and Business Overview
Table 154. Apotex Risperidone Sales (K Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 155. Apotex Risperidone Product
Table 156. Apotex Recent Development
Table 157. Celltrion Corporation Information
Table 158. Celltrion Introduction and Business Overview
Table 159. Celltrion Risperidone Sales (K Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 160. Celltrion Risperidone Product
Table 161. Celltrion Recent Development
Table 162. Dr. Reddy's Laboratories Corporation Information
Table 163. Dr. Reddy's Laboratories Introduction and Business Overview
Table 164. Dr. Reddy's Laboratories Risperidone Sales (K Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 165. Dr. Reddy's Laboratories Risperidone Product
Table 166. Dr. Reddy's Laboratories Recent Development
Table 167. Torrent Pharmaceuticals Corporation Information
Table 168. Torrent Pharmaceuticals Introduction and Business Overview
Table 169. Torrent Pharmaceuticals Risperidone Sales (K Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 170. Torrent Pharmaceuticals Risperidone Product
Table 171. Torrent Pharmaceuticals Recent Development
Table 172. Luye Pharma Group Corporation Information
Table 173. Luye Pharma Group Introduction and Business Overview
Table 174. Luye Pharma Group Risperidone Sales (K Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 175. Luye Pharma Group Risperidone Product
Table 176. Luye Pharma Group Recent Development
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Risperidone Market Trends
Table 180. Risperidone Market Drivers
Table 181. Risperidone Market Challenges
Table 182. Risperidone Market Restraints
Table 183. Risperidone Distributors List
Table 184. Risperidone Downstream Customers
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Risperidone Product Picture
Figure 2. Global Risperidone Market Size, 2017 VS 2021 VS 2028 (US$ Million)
Figure 3. Global Risperidone Market Size Status and Outlook (2017-2028) & (US$ Million)
Figure 4. Global Risperidone Sales Status and Outlook (2017-2028) & (K Pcs)
Figure 5. Product Picture of Tablet
Figure 6. Global Tablet Sales YoY Growth (2017-2028) & (K Pcs)
Figure 7. Product Picture of Oral Solution
Figure 8. Global Oral Solution Sales YoY Growth (2017-2028) & (K Pcs)
Figure 9. Global Risperidone Sales by Type (2017-2028) & (US$ Million)
Figure 10. Global Risperidone Sales Market Share in Volume by Type (2017-2022)
Figure 11. Global Risperidone Sales Market Share in Value by Type (2017-2022)
Figure 12. Global Risperidone Sales Market Share in Volume by Type (2023-2028)
Figure 13. Global Risperidone Sales Market Share in Value by Type (2023-2028)
Figure 14. North America Risperidone Sales Market Share in Volume by Type in 2021
Figure 15. North America Risperidone Sales Market Share in Value by Type in 2021
Figure 16. Europe Risperidone Sales Market Share in Volume by Type in 2021
Figure 17. Europe Risperidone Sales Market Share in Value by Type in 2021
Figure 18. Asia-Pacific Risperidone Sales Market Share in Volume by Type in 2021
Figure 19. Asia-Pacific Risperidone Sales Market Share in Value by Type in 2021
Figure 20. South America Risperidone Sales Market Share in Volume by Type in 2021
Figure 21. South America Risperidone Sales Market Share in Value by Type in 2021
Figure 22. Middle East and Africa Risperidone Sales Market Share in Volume by Type in 2021
Figure 23. Middle East and Africa Risperidone Sales Market Share in Value by Type in 2021
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Risperidone Sales in 2021
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Risperidone Revenue in 2021
Figure 26. Risperidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 27. Product Picture of Schizophrenia
Figure 28. Global Schizophrenia Sales YoY Growth (2017-2028) & (K Pcs)
Figure 29. Product Picture of Bipolar Disorder
Figure 30. Global Bipolar Disorder Sales YoY Growth (2017-2028) & (K Pcs)
Figure 31. Global Risperidone Sales by Application (2017-2028) & (US$ Million)
Figure 32. Global Risperidone Sales Market Share by Application in 2021 & 2028
Figure 33. North America Risperidone Sales Market Share in Volume by Application in 2021
Figure 34. South America Risperidone Sales Market Share in Value by Application in 2021
Figure 35. Middle East and Africa Risperidone Sales Market Share in Value by Application in 2021
Figure 36. Key Raw Materials Price
Figure 37. Risperidone Manufacturing Cost Structure
Figure 38. Risperidone Industrial Chain Analysis
Figure 39. Channels of Distribution
Figure 40. Distributors Profiles
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
  • Global Divalproex Sodium Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 81
    Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in The brain tissue to stop seizures. Divalproex Sodium is also used to treat The manic phase of bipolar disorder (manic-depressive illness), and helps prevent migraine headaches. This medicine is available only with your doctor's prescription. The global Divalproex Sodium market was valued at US$ 2188.5 million in 2023 and is anticipated to reach US$ 33......
  • Global Divalproex Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Divalproex Sodium market size was valued at US$ 2140.9 million in 2023. With growing demand in downstream market, the Divalproex Sodium is forecast to a readjusted size of US$ 3312 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Divalproex Sodium market. Divalproex Sodium are expected to show stable growth in the future market. However, product differ......
  • Global Quetiapine Fumarate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Quetiapine Fumarate market size was valued at US$ 156.2 million in 2023. With growing demand in downstream market, the Quetiapine Fumarate is forecast to a readjusted size of US$ 132.9 million by 2030 with a CAGR of -2.3% during review period. The research report highlights the growth potential of the global Quetiapine Fumarate market. Quetiapine Fumarate are expected to show stable growth in the future market. However, produ......
  • Global Clozapine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Clozapine market size was valued at US$ 341.4 million in 2023. With growing demand in downstream market, the Clozapine is forecast to a readjusted size of US$ 463.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Clozapine market. Clozapine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Trazodone Hydrochloride (API) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 92
    According to our LPI (LP Information) latest study, the global Trazodone Hydrochloride (API) market size was valued at US$ million in 2023. With growing demand in downstream market, the Trazodone Hydrochloride (API) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Trazodone Hydrochloride (API) market. Trazodone Hydrochloride (API) are expected to show stable growth in the future......
  • Global Trazodone Hydrochloride (API) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 93
    According to our (Global Info Research) latest study, the global Trazodone Hydrochloride (API) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Trazodone, a phenylpiperazine-triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety an......
  • Global Divalproex Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Divalproex Sodium market size was valued at USD 2251.9 million in 2023 and is forecast to a readjusted size of USD 3371.1 million by 2030 with a CAGR of 5.9% during review period. Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in the brain tissue to stop seizures. Divalproex Sodium is also used to treat the manic phase of bipolar disorder (manic-d......
  • Global Risperidone Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 93
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Risperidone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Janssen (Johnson & Johnson) - Ajanta Pharma - Amneal Pharmaceuticals - Aurobindo Pharma - Hikma - Sandoz - Lannett - Tris Pharma - Ap......
  • Global Schizophrenia Therapeutics Market Status and Outlook 2023-2028
    Published: 27-Dec-2023        Price: US 3160 Onwards        Pages: 101
    Schizophrenia is usually treated with an individually tailored combination of talking therapy and medicine. Most people with schizophrenia are treated by community mental health teams (CMHTs). The goal of the CMHT is to provide day-to-day support and treatment while ensuring you have as much independence as possible. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market va......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs